|
|
||||||||
Published online before print May 15, 2007
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||





* Istituto di Patologia Generale, Università di Milano, Italy;
Dipartimento di Scienze Mediche, Università "A. Avogadro," Novara, Italy;
Dipartimento di Medicina Sperimentale, Università di Genova, Italy; and
Istituto Clinico Humanitas, IRCCS, Rozzano, Italy
1 Correspondence: Istituto di Patologia Generale, University of Milan School of Medicine, Via Mangiagalli 31, 20133 Milano, Italy. E-mail: gaetano.cairo{at}unimi.it
Adenosine released by cells in injurious or hypoxic environments has tissue-protecting and anti-inflammatory effects, which are also a result of modulation of macrophage functions, such as vascular endothelial growth factor (VEGF) production. As VEGF is a well-known target of hypoxia-inducible factor 1 (HIF-1), we hypothesized that adenosine may activate HIF-1 directly. Our studies using subtype-specific adenosine receptor agonists and antagonists showed that by activating the A2A receptor, adenosine treatment induced HIF-1 DNA-binding activity, nuclear accumulation, and transactivation capacity in J774A.1 mouse macrophages. Increased HIF-1 levels were also found in adenosine-treated mouse peritoneal macrophages. The HIF-1 activation induced by the A2A receptor-specific agonist CGS21680 required the PI-3K and protein kinase C pathways but was not mediated by changes in iron levels. Investigation of the molecular basis of HIF-1 activation revealed the involvement of transcriptional and to a larger extent, translational mechanisms. HIF-1 induction triggered the expression of HIF-1 target genes involved in cell survival (aldolase, phosphoglycerate kinase) and VEGF but did not induce inflammation-related genes regulated by HIF-1, such as TNF-
or CXCR4. Our results show that the formation of adenosine and induction of HIF-1, two events which occur in response to hypoxia, are linked directly and suggest that HIF-1 activation through A2A receptors may contribute to the anti-inflammatory and tissue-protecting activity of adenosine.
Key Words: hypoxia inflammation kinases
This article has been cited by other articles:
![]() |
M. V. Sitkovsky, J. Kjaergaard, D. Lukashev, and A. Ohta Hypoxia-Adenosinergic Immunosuppression: Tumor Protection by T Regulatory Cells and Cancerous Tissue Hypoxia Clin. Cancer Res., October 1, 2008; 14(19): 5947 - 5952. [Abstract] [Full Text] [PDF] |
||||
![]() |
M.-C. Lee, S.-C. Wei, J.-J. Tsai-Wu, C. H. H. Wu, and P.-N. Tsao Novel PKC signaling is required for LPS-induced soluble Flt-1 expression in macrophages J. Leukoc. Biol., September 1, 2008; 84(3): 835 - 841. [Abstract] [Full Text] [PDF] |
||||
![]() |
L. Tacchini, E. Gammella, C. De Ponti, S. Recalcati, and G. Cairo Role of HIF-1 and NF-{kappa}B Transcription Factors in the Modulation of Transferrin Receptor by Inflammatory and Anti-inflammatory Signals J. Biol. Chem., July 25, 2008; 283(30): 20674 - 20686. [Abstract] [Full Text] [PDF] |
||||
![]() |
G. Hasko and P. Pacher A2A receptors in inflammation and injury: lessons learned from transgenic animals J. Leukoc. Biol., March 1, 2008; 83(3): 447 - 455. [Abstract] [Full Text] [PDF] |
||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |